Prostate Cancer
Latest News
Outside the Guidelines: Denosumab Overuse in Prostate Cancer
For patients with metastatic castration-sensitive disease the bone-modifying agents show no benefit in preventing skeletal-related events, are not...
News
Is MRI Screening Unnecessarily High in Prostate Cancer?
Expert emphasizes the necessity of observing a decrease in overall prostate cancer incidence before asserting that the current cancer diagnostics...
News
Focal Therapy for Prostate Cancer: Evidence-Based or Oversold?
Richard LaFrate’s urologist asked him to pay $25,000 out of pocket to undergo a focal procedure at a clinic in the Bahamas.
Latest News
Plant-Based Diet a Boon for Men With Prostate Cancer
A diet of fresh vegetables and fruit with few animal-based products is linked to reduced risk for recurrent prostate cancer, says study.
Latest News
Cardiorespiratory Fitness May Cut Prostate Cancer Risk
The association between change in absolute CRF and prostate cancer incidence was significant only for participants with a moderate baseline...
Conference Coverage
Small PFS gain in metastatic prostate cancer with TKI and ICI
Expert questions the choice of an androgen receptor pathway inhibitor (ARPI) switch as the control arm of the study.
Conference Coverage
Combo Tx Best in Metastatic Prostate Cancer with HRR Mutations
PFS was better with abiraterone/prednisone and olaparib vs. monotherapy in men with metastatic castration-resistant prostate cancer with DNA...
News
More Side Effects With Local Therapies for Prostate Cancer
What impact does local therapy have on the men’s quality of life?
Conference Coverage
High-dose RT and long-term ADT improve survival in high-risk prostate cancer
These results are “practice-affirming for many,” according to an expert commenting on the new findings.
News
Functional Outcomes in Localized Prostate Cancer: Treatment Choice, Time, Prognosis All Matter
New study sheds light on quality of life effects related to disease severity and treatment choice.
